You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival

Article metrics

Article menu

Download PDFPDF

Clinical/translational cancer immunotherapy
Original research
Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival

 

Online download statistics by month:

Online download statistics by month: January 2021 to February 2026

AbstractFullPdf
Jan 2021586589154
Feb 2021415416106
Mar 202124324365
Apr 202115015077
May 202113113156
Jun 202111911934
Jul 202111911937
Aug 202113613657
Sep 2021898938
Oct 202112212245
Nov 202114814761
Dec 202112512735
Jan 20229610047
Feb 2022909344
Mar 2022888833
Apr 202210010241
May 202211111339
Jun 202213213451
Jul 202212212538
Aug 202213313437
Sep 202211211438
Oct 202211311661
Nov 202210214857
Dec 2022949422
Jan 2023777721
Feb 202311711740
Mar 202312412634
Apr 2023888926
May 2023838412
Jun 2023717116
Jul 2023787824
Aug 202310910931
Sep 2023666619
Oct 2023969634
Nov 2023909026
Dec 202310310523
Jan 2024363827
Feb 2024717123
Mar 2024717183
Apr 202410110134
May 2024969625
Jun 20249910019
Jul 202412612721
Aug 2024636022
Sep 2024848426
Oct 2024858526
Nov 202411711834
Dec 202410810926
Jan 202515515542
Feb 202519019033
Mar 202510410445
Apr 202516016340
May 202511511548
Jun 2025949417
Jul 2025110
Feb 2026110
Total665567402170